Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Daktavira

Daktavira :
Type Medicine Authorised
Originator Daklinza*
Agent C. Catafago & Co
Distributor C. Catafago & Co
Laboratory EEP
Responsible Party European Egyptian Pharmaceutical Industries
Origin Egypt
Manufacturer European Egyptian Pharmaceutical Industries
Manufacturing Type G
Origin Egypt
ATC J05AP07

Your comment will appear shortly after approval

Daktavira :

Revision Date : 22/08/2014


Effect Frequency
Abdominal pain upper Common
Alopecia Common
Anaemia Common
Anxiety Common
Arthralgia (Pain joint) (Joint ache) Common
Asthenia Not known
Atrioventricular block (AVB) Not known
Bradycardia Not known
Constipation Common
Cough Common
Decreased appetite Common
Depression Common
Diarrhoea (Diarrhea) Common
Dizziness Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dyspnoea (dyspnea) Common
Dyspnoea exertional Common
Fatigue Very Common
Flatulence Common
Gastrooesophageal reflux disease Common
Haemoglobin decreased Not known
Headache Very Common
Hot flush Common
Influenza-like illness Not known
Insomnia Common
Irritability Common
Lymphopenia Not known
Migraine Common
Myalgia Common
Nasal congestion Common
Nausea Very Common
Neutropenia Not known
Pruritus Common
Pyrexia Not known
Skin rash Common
Vomiting Common

Different Units By MoH Code

Daktavira  MoH 9328 :
Form Tablet, Film-Coated
Packaging Plastic Bottle
Package Size Box of 28
Strength 60mg
Storage Condition <30°C Away from moisture
Stratum ?
NSSF ✘
Quarantine ✘
Reg. Number 143517/1
Submission date 01/01/2017
Registration Year 2018


Price Comparison

● Country: Egypt
● Package Size: 28
● Public Price: 120 EGP ( 219,000.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 4,2857 EGP ( 7,300.00 LBP )
● Pricing Date: 20/11/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info